惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

A
About on SuperTechFans
C
Cybersecurity and Infrastructure Security Agency CISA
N
News and Events Feed by Topic
C
Cisco Blogs
Cisco Talos Blog
Cisco Talos Blog
A
Arctic Wolf
Scott Helme
Scott Helme
P
Palo Alto Networks Blog
S
Schneier on Security
D
Darknet – Hacking Tools, Hacker News & Cyber Security
T
Tor Project blog
量子位
G
Google Developers Blog
H
Hackread – Cybersecurity News, Data Breaches, AI and More
B
Blog RSS Feed
NISL@THU
NISL@THU
Exploit-DB.com RSS Feed
Exploit-DB.com RSS Feed
AWS News Blog
AWS News Blog
爱范儿
爱范儿
Last Week in AI
Last Week in AI
Y
Y Combinator Blog
L
LINUX DO - 最新话题
Security Archives - TechRepublic
Security Archives - TechRepublic
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
S
Secure Thoughts
Cloudbric
Cloudbric
aimingoo的专栏
aimingoo的专栏
L
Lohrmann on Cybersecurity
TaoSecurity Blog
TaoSecurity Blog
Recent Commits to openclaw:main
Recent Commits to openclaw:main
Hacker News: Ask HN
Hacker News: Ask HN
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
The GitHub Blog
The GitHub Blog
有赞技术团队
有赞技术团队
S
Security @ Cisco Blogs
cs.CL updates on arXiv.org
cs.CL updates on arXiv.org
C
Cyber Attacks, Cyber Crime and Cyber Security
G
GRAHAM CLULEY
P
Proofpoint News Feed
V
V2EX
Martin Fowler
Martin Fowler
C
CERT Recently Published Vulnerability Notes
Attack and Defense Labs
Attack and Defense Labs
C
CXSECURITY Database RSS Feed - CXSecurity.com
The Cloudflare Blog
SecWiki News
SecWiki News
罗磊的独立博客
CTFtime.org: upcoming CTF events
CTFtime.org: upcoming CTF events
小众软件
小众软件
The Last Watchdog
The Last Watchdog

Stocks Fundamentals Analysis India | The HinduBusinessLine

Who Am I? June 21, 2026 Shyam Metalics: What Should Investors Do? Turtlemint Fintech Solutions IPO: Should You Subscribe? Covers for Cancer Treatment Wonderla, V-Guard, Havells, Voltas, UBL, Blue Star, Emami: Hot Summer, Cold Stocks? Why Buy This Luxury Hotel on Dips Who Am I? June 14, 2026 Polycab India: What Should Investors Do? Kotak Mahindra Bank: Good time to relook? Who Am I? June 7, 2026 Cipla: Tonic For The Patient Investor JSW Steel: Will plans to double capacity boost stock price? Emami stock: Why this FMCG stock is a buy near its 52-week low Who Am I? May 31, 2026 Medanta: What Should Investors Do? Should investors buy HDFC Bank now? SpaceX IPO and the Big Bang Bubble Who Am I? May 24, 2026 Simply Put: Interest Coverage Ratio Who Am I? May 17, 2026 What They Say on Their India Plans SRF: On The Road to Recovery Godrej Agrovet Accumulate Call Palm Oil Animal Nutrition Outlook The Ramco Cements: What Should Investors Do? Nifty 50, Nifty 500: PE multiples can be the same number yet poles apart SAMHI Hotels stock call: Accumulate on dips What They Say on Their India Plans Who Am I? May 10, 2026 Who Am I? May 3, 2026 What They Say on Their India Plans Wait for the fog to clear first! Steel Authority of India: With SAIL shares at a 15-year high, what should investors do? Sun Pharma-Organon deal: Outlook is mixed Banking on valuation comfort Jyothy Labs: Why the stock is a buy after 30 pc drop in last 1 year What They Say on Their India Plans Who Am I? April 26, 2026 HDFC Bank: Key takeaways for investors from Q4 results Narayana Health: Heart At The Right Place Who Am I? April 19, 2026 Citius TransNet InvIT IPO: Should you apply? What the numbers say The sector call illusion Caplin Point: Consolidating before the next leg of growth Who Am I? April 12, 2026 Who Am I? April 5, 2026 Zydus Lifesciences: Bridging the gap What should investors do about Bosch shares New India Assurance stock call: Should investors accumulate on dips? Will this engineering behemoth stock fix the dented investor confidence? Who Am I? March 29, 2026 Equities, Bonds, Commodities, Currencies et al: How They Fare Three Weeks into the US-Iran War Navin Fluorine: What Should You Do? Who Am I? March 22, 2026 HDFC Bank’s Part-time Chairman resigns: What investors need to know CMPDI IPO Review: Subscribe to Central Mine Planning & Design Institute Issue? Who Am I? March 15, 2026 Ambuja Cements: What Should You Do? IHCL stock: Accumulate on dips after correction Raajmarg Infra Investment Trust IPO: Should you invest? AMC stocks defy markets, enjoy outperformance and premium valuations United Breweries Hold Call: Margin Gains Help, But Valuation Remains Rich PG Electroplast stock: Hot Summer, Hotter Sales Who Am I? March 8, 2026 Should you subscribe to Sedemac Mechatronics IPO? Who Am I? March 1, 2026 ITC Hotels: Accumulate on dips as valuation cools and asset-light growth gathers pace Lumax Industries: Should You Book Profit After The Small-Cap’s Stellar Run? What They Say on Their India Plans DLF: A Premium Residential and Commercial Spaces Play Clean Max IPO: Should You Subscribe? Who Am I? Feb 22, 2026 Tata Motors: What investors need to know about the demerged commercial vehicle business Who Am I? Feb 15, 2026 Sun Pharma: What should investors do? What the merger of PFC and REC means for investors India Inc delivers well in Q3 FY26 NBCC: A Solid Construction Play on Government Capex Fractal Analytics IPO review: Valuation looks demanding amid AI disruption Who Am I? Feb 8, 2026 How market fares around Budgets Dr. Reddy and Cipla: Growth in the post-Lenalidomide era for pharma stocks Who Am I? Feb 1, 2026 Who Am I? Jan 25, 2026 Should You Consider Buying Bank of Maharashtra’s Stock? What investors need to glean from HDFC Bank’s Q3 results Neuland Laboratories: What Should Investors Do? Who Am I? Jan 18, 2026 Shadowfax IPO Review: Fast Growth, Thin Margins — Subscribe or Wait? Amagi Media Labs IPO: Are valuations outpacing profits for this SaaS company? Nexus Select Trust: Yielding More on Urban Consumption Who Am I? Jan 11, 2026 BCCL IPO: Cheap on paper, costly in a downcycle; why Coal India may be the smarter pick Mankind Pharma: Finding synergies amidst transformation What Should Investors Do About The PNB Housing Finance Stock? Who Am I? Jan 4, 2026 Chalet Hotels: Buy, Sell or Hold? Shree Cement: What Should Investors Do? Who Am I? Dec 28, 2025 Decoding Life Insurers ICICI Prudential Life: Is The Least Expensive Life Insurer A Good Bet Now?
Banking on a transformation
By Nishanth Gopalakrishnan · 2026-04-11 · via Stocks Fundamentals Analysis India | The HinduBusinessLine

We had given an ‘accumulate’ call on the stock of CSB Bank in February 2025 (after Q3 FY25 results), when the stock was trading at ₹306 or 1.2x its book value. The GNPA ratio then was 1.6 per cent. RoA (return on assets) for Q3 FY25 and 9M FY25 came in at 1.5 per cent and 1.4 per cent respectively.

Since our call, the stock made a 52-week high of ₹575 in early January 2026, reflecting strong growth in business— advances grew 30 per cent in FY25 and 29 per cent in H1 FY26. At this price, the P/B (price-to-book value) multiple works out to 2x. This, despite the bank’s GNPA ratio rising to 1.8 per cent. However, the stock started correcting soon, more steeply so towards the end of January, when gold price dropped sharply (gold loans account for half of the loan book). With Q3 earnings release coinciding, it only added to the selling pressure. The stock is now at a 30-per cent discount to its 52-week high.

The bank reported a 29 per cent and 21 per cent rise in advances and deposits in Q3 FY26. Net interest and fee income grew well, helping the bank post a 32 per cent growth in pre-provisioning operating profit (34 per cent in 9M FY26). However, the bad news came from asset quality. Provisionsfor NPAs rose to ₹77 crore from a mere ₹7 crore a year ago and ₹55 crore a quarter ago. Credit cost reached 0.7 per cent, which had been around 0.5 per cent in Q1 and Q2. GNPA ratio worsened to 2 per cent. Net profit growth was flat for the quarter and just about 7 per cent for 9M FY26. RoA for 9M FY26 slipped to 1.2 per cent. All these largely had to do with the bank’s SME portfolio, which accounts for about 12 per cent of gross advances. Yet, the bank is reasonably comfortable for the reasons included below.

Also, CSB is in the process of scaling up into a full-service bank by FY30 (discussed below) from being a gold-loan focused financier (current loan-book is just over ₹37,000 crore). Tech/ system upgrades to support this are largely done, and the bank would enter the ‘scale’ phase from FY27. That said, FY27 would still be the first year in this phase and there may be initial hiccups in execution. Benefits are likely to accrue from FY28. CSB does have a fairly large footprint with about 850 branches to support the scale-up, comparable with Karur Vysya Bank’s 900 branches (loan book of ₹97,000 crore).

The two-week ceasefire helps one hope the energy crisis may not prolong to cause large-scale disruption to businesses, especially for SMEs. This coupled with the facts on SME book stated below put the bank in a reasonably-comfortable spot. However, this may not hold true if the crisis prolongs. This along with any execution hiccups in FY27 may cause some corrections in the share price, opening up buying opportunities.

The stock currently trades at 1.5x its book value. The five-year average P/B ratio is 1.6x. With the worst of credit cost behind, the management expects RoA to return to 1.5 per cent by FY28. The transformed and scaled-up bank by FY30 should be more resilient with a larger but granular franchise, no longer heavily dependent on gold loans. Therefore, we suggest investors with a horizon of three years or more to accumulate the stock on dips of 10 per cent or more, as margin of safety is more comfortable at those levels or lower.

SME trouble

Gold loans, corporate loans, SME loans and retail loans share the ₹37,000-crore-odd loan-book in a 51:24:12:13 ratio. Gold and corporate portfolios are performing all right. But SME and retail aren’t and thus dominate the slippages. Some portions of the retail book such as two-wheeler, agri and microfinance loans experience stress and so the bank is consciously not growing them. Slippages from older accounts continue to show up though. Rest of the retail book appears to do well.

SME is the bigger problem. Slippages are primarily from those borrowers whose businesses were adversely affected by Trump’s tariffs. The management has cut back on disbursements—from an average growth of 47 per cent year-on-year in the quarters of FY25 to an average -7 per cent in 9M FY26. However, the management is optimistic about the book as they have seen some accounts being upgraded as ‘performing’ in Q4 itself and the expectation is that about half of the slipped accounts would have been upgraded by March-end. Further, about 80 per cent of the SME book is collateralised.

Otherwise too, the bank has buffers from accelerated provisions and contingency provisions. Capital adequacy ratio is healthy at 19.4 per cent.

Gold loan LTV

Since late January, gold has corrected about 10 per cent. This is negative for CSB as it would move the LTV (loan-to-value) ratio of gold loans higher. If the ratio breaches the regulatory threshold (75-85 per cent based on the loan amount), it will lead to margin calls. LTV ratio stands at 63 per cent as of Q3 FY26.

The management has stated that it does not take price risk with gold loans—meaning it does not take advantage of higher gold prices to lend more. Working with current gold price (13 per cent up from December 31, 2026) and accrued interest for Q4 FY26, the LTV works out to 57-59 per cent. Our estimates suggest that gold should fall at least 20 per cent from the current level for the LTV ratio to reach 75 per cent.

Vision 2030

A key reason why the bank has not been able to expand into a full-service bank is the absence of systems to support diverse products. For instance, a new product like LAP (loan against property) would need its own suite of systems including the underwriting engine. CSB has invested in the same and the upgrades are largely in place now. By FY30, it envisages a loan-book mix of gold loans 25-30 per cent, corporate 30 per cent+, SME 18-20 per cent and the rest from retail.

Once the products are in place, the bank can raise low-cost deposits unlike now, where 40 per cent of deposits are bulk deposits and low-cost CASA balances are just 21 per cent. In the above example, a LAP loan can typically spawn a current account. This could bring cost of funds down and aid higher RoA. However, with non-gold loans dominating the book, yield on advances would largely come to track benchmarks unlike now, where about 60 per cent of the book (mainly due to gold) is based on fixed interest rates. Cost-to-income ratio falling to 50 per cent with scale (63 per cent for 9M FY26) can help offset this.

Published on April 11, 2026